These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 16368308)

  • 1. Impact of renal insufficiency on outcome after contemporary percutaneous coronary intervention.
    Blackman DJ; Pinto R; Ross JR; Seidelin PH; Ing D; Jackevicius C; Mackie K; Chan C; Dzavik V
    Am Heart J; 2006 Jan; 151(1):146-52. PubMed ID: 16368308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of moderate or severe renal insufficiency on long-term outcomes in patients undergoing drug-eluting stent based coronary intervention.
    Zhang RY; Zhu ZB; Zhang Q; Yang ZK; Hu J; Lv AK; Zhang JS; Shen WF
    Int J Cardiol; 2009 Jul; 136(1):72-9. PubMed ID: 18653250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal impairment is an independent predictor of adverse events post coronary intervention in patients with and without drug-eluting stents.
    Shaw JA; Andrianopoulos N; Duffy S; Walton AS; Clark D; Lew R; Sebastian M; New G; Brennan A; Reid C; Ajani AE;
    Cardiovasc Revasc Med; 2008; 9(4):218-23. PubMed ID: 18928945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence, predictors, and outcomes of post-percutaneous coronary intervention nephropathy in patients with diabetes mellitus and normal baseline serum creatinine levels.
    Roy P; Raya V; Okabe T; Pinto Slottow TL; Steinberg DH; Smith K; Xue Z; Satler LF; Kent KM; Suddath WO; Pichard AD; Lindsay J; Waksman R
    Am J Cardiol; 2008 Jun; 101(11):1544-9. PubMed ID: 18489931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of moderate renal insufficiency on restenosis and adverse clinical events after sirolimus-eluting and bare metal stent implantation (from the SIRIUS trials).
    Garg P; Charytan DM; Novack L; Cutlip DE; Popma JJ; Moses J; Leon MB; Schofer J; Breithardt G; Schampaert E; Mauri L
    Am J Cardiol; 2010 Nov; 106(10):1436-42. PubMed ID: 21059433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long term clinical outcomes in patients with moderate renal insufficiency undergoing stent based percutaneous coronary intervention.
    Zhang RY; Ni JW; Zhang JS; Hu J; Yang ZK; Zhang Q; Lü AK; Shen WF
    Chin Med J (Engl); 2006 Jul; 119(14):1176-81. PubMed ID: 16863609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence, predictors, and clinical impact of bleeding after transradial coronary stenting and maximal antiplatelet therapy.
    Bertrand OF; Larose E; Rodés-Cabau J; Gleeton O; Taillon I; Roy L; Poirier P; Costerousse O; Larochellière RD
    Am Heart J; 2009 Jan; 157(1):164-9. PubMed ID: 19081414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of renal insufficiency on short- and long-term outcomes after cardiac surgery.
    Lok CE; Austin PC; Wang H; Tu JV
    Am Heart J; 2004 Sep; 148(3):430-8. PubMed ID: 15389229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of admission creatinine level on clinical outcomes of patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention with drug-eluting stent implantation.
    Zhang Q; Zhang RY; Shen J; Zhang JS; Hu J; Yang ZK; Zhang X; Zheng AF; Shen WF
    Chin Med J (Engl); 2008 Dec; 121(23):2379-83. PubMed ID: 19102952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical benefits of adjunctive tirofiban therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Shen J; Zhang Q; Zhang RY; Zhang JS; Hu J; Yang ZK; Zheng AF; Zhang X; Shen WF
    Coron Artery Dis; 2008 Jun; 19(4):271-7. PubMed ID: 18480672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of renal function on the long-term clinical course of patients who underwent percutaneous coronary intervention.
    Papafaklis MI; Naka KK; Papamichael ND; Kolios G; Sioros L; Sclerou V; Katsouras CS; Michalis LK
    Catheter Cardiovasc Interv; 2007 Feb; 69(2):189-97. PubMed ID: 17253600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of gender on the incidence and outcome of contrast-induced nephropathy after percutaneous coronary intervention.
    Iakovou I; Dangas G; Mehran R; Lansky AJ; Ashby DT; Fahy M; Mintz GS; Kent KM; Pichard AD; Satler LF; Stone GW; Leon MB
    J Invasive Cardiol; 2003 Jan; 15(1):18-22. PubMed ID: 12499523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy and safety of short- and long-term dual antiplatelet therapy in patients with mild or moderate chronic kidney disease: results from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial.
    Best PJ; Steinhubl SR; Berger PB; Dasgupta A; Brennan DM; Szczech LA; Califf RM; Topol EJ;
    Am Heart J; 2008 Apr; 155(4):687-93. PubMed ID: 18371477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal insufficiency increases mortality in acute coronary syndromes regardless of TIMI risk score.
    Dudek D; Chyrchel B; Siudak Z; Depukat R; Chyrchel M; Dziewierz A; Mielecki W; Rakowski T; Rzeszutko Ł; Dubiel J
    Kardiol Pol; 2008 Jan; 66(1):28-34; discussion 35-6. PubMed ID: 18266185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-based differences of percutaneous coronary intervention in the drug-eluting stent era.
    Floyd KC; Jayne JE; Kaplan AV; Friedman BJ; Niles NW; Hettleman BD; Robb JF; Thompson CA
    J Interv Cardiol; 2006 Oct; 19(5):381-7. PubMed ID: 17020561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness and cost-effectiveness of facilitated percutaneous coronary intervention compared with primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction transferred from community hospitals.
    Coleman CI; McKay RG; Boden WE; Mather JF; White CM
    Clin Ther; 2006 Jul; 28(7):1054-62. PubMed ID: 16990084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk stratification according to the type of impaired renal function in patients with acute myocardial infarction treated with percutaneous coronary intervention.
    Kowalczyk J; Lenarczyk R; Kowalski O; Swiatkowski A; Stabryła-Deska J; Kurek T; Honisz G; Kukulski T; Gasior M; Kalarus Z
    Kardiol Pol; 2007 Jun; 65(6):635-43; discussion 644. PubMed ID: 17629825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of sex on in-hospital outcomes and long-term survival after contemporary percutaneous coronary intervention.
    Berger JS; Sanborn TA; Sherman W; Brown DL
    Am Heart J; 2006 May; 151(5):1026-31. PubMed ID: 16644329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased complication rates using the transradial compared to the transfemoral approach in percutaneous coronary intervention in the era of routine stenting and glycoprotein platelet IIb/IIIa inhibitor use: a large single-center experience.
    Eichhöfer J; Horlick E; Ivanov J; Seidelin PH; Ross JR; Ing D; Daly P; Mackie K; Ridley B; Schwartz L; Barolet A; Dzavík V
    Am Heart J; 2008 Nov; 156(5):864-70. PubMed ID: 19061699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of outcomes of percutaneous coronary interventions in patients of three age groups (<60, 60 to 80, and >80 years) (from the New York State Angioplasty Registry).
    Feldman DN; Gade CL; Slotwiner AJ; Parikh M; Bergman G; Wong SC; Minutello RM;
    Am J Cardiol; 2006 Nov; 98(10):1334-9. PubMed ID: 17134624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.